Eureka Institute.
Translational FINMED
LocationOnline
Date24 - 26 Sept 2021
Timing5 three hour sessions (Friday afternoon, Saturday, Sunday); Based on Italian timezone.
Number of Participants20+
Target Participants
  • Business and bio-medical professionals leading translational innovation in biopharmaceutical, research institutions, private and public healthcare organisations
  • Executives driving top-line growth, managing portfolios, or tasked with creating new business models into medical care industries will also benefit;
  • Professionals interested in starting their own business or pursuing managerial careers in design-driven companies, communications or branding agencies, or consulting firms in the healthcare sector
Course Fees1,200 Euros per pax (discounts available for Eureka members)
Course Objectives
  • Participants who come from a scientific background will understand how to design business models and will be better able to attract investors and funds
  • Managers & investors will develop their Translational Medicine (TM) knowledge and understand how it increases their competitive advantage and leads to opportunities to develop their business
RegistrationComing Soon!

TRANSLATIONAL FINMED (TFM COURSE)

TFM Course is a new advanced educational project to better understand Translational Medicine challenges in a unique, innovative, managerial and financial mindset.

Translational Medicine (TM) is an innovative and rapidly growing knowledge area, able to speed up research & development (R&D) processes and time to market strategies for new and innovative treatments, instruments, devices and diagnostic tools by using a multi-disciplinary, highly collaborative approach. TM requires “new translational profiles and skills” with different backgrounds coming from R&D departments, Healthcare organisations, Pharmaceutical / Biopharmaceutical Companies and Institutions, Financial companies and institutions, Start uppers and Professionals, equipped to bridge the gap between clinical investigation, technological and management and financial fundamentals.

Such TM unique and transversal skills are becoming crucial in evaluating and exploiting health care research to efficiently meet diagnostic and therapeutic needs. Transitioning from vertical, functional and specialised know how into a multidisciplinary-translational approach combining health care mindset with management fundamentals, will provide unique hybrid knowledge in areas such as trial design, intellectual proprieties, and leadership.

Session Highlights
24 Sept (Friday)25 Sept (Saturday)26 Sept (Sunday)

Overview of Translational Medicine

The “Patient centered care TM perspectives”: building value by understanding the needs

How to Evaluate and Assess the Economic and Social Impact

 

 

 

 

 

 

What makes a technology “druggable”: Idea Development: Create and Implement Innovative Ideas-Resourced based approach

Intellectual Property Law and Policy, Licensing

Principles of Preclinical and Clinical Development

Translational Medicine Life Cycle and Steps. Business creation and development life cycle and steps: How to govern the interaction and alignment of the two life cycles

Getting your bearings: A Finance for Innovation General Framework: The Main Pillars

 

Open Innovation Networks: Insights from Life Science Industries

False Myths and True Practices on tech transfer and science-based start-ups

Going to market and entry-exit strategy

Bio Clusters and co-location in ecosystems – Leading change and Innovation and Networking

 

 

 

 

 

Faculty List

Prof Andrea Prencipe, LUISS University

Prof Berent Prakken, University Medical Center Utrecht

Prof Carmela Elita Schillaci, University of Catania

Prof Elia Stupka, HIVES

Prof Elio Borgonovi, Bocconi University

Prof Isabella Castiglioni, Bocconi University

Prof Maria-Grazia Roncarolo, Stanford University

Prof Maurizio Dallocchio, Bocconi University

Prof Michele Costabile, LUISS University

Prof Patrick H. Maxwell, Cambridge University

Prof Salvatore Albani, Duke-NUS Medical School

Prof Tom Hockaday, Oxford University Innovation

Mr Wainwright Fishburn, Cooley LLP, San Diego  

Jointly Organised By

Top